Deprescribing in Older Adults | Geriatric Pharmacotherapy [SIMCON 2023]

Added:

Therapeutic Undertreatment and Adverse Drug Withdrawal Risks

While deprescribing aims to reduce polypharmacy, critics highlight the risks of therapeutic undertreatment (sometimes termed geriatric therapeutic nihilism) and adverse drug withdrawal events (ADWEs). Aggressive deprescribing can trigger the relapse of well-controlled chronic conditions, such as hypertension, heart failure, or psychiatric disorders, when essential medications are inappropriately stopped. Additionally, critics point out a shortage of robust, long-term randomized controlled trial (RCT) evidence proving that deprescribing consistently reduces mortality or improves quality of life. This counterpoint advocates for 'appropriate prescribing'—emphasizing that managing complex conditions in older adults often requires polypharmacy, and that a dogmatic focus on reducing pill counts can inadvertently lead to patient harm and substandard care.

Understanding the physiological changes of aging and their impact on pharmacokinetics and pharmacodynamics.
The definition and clinical implications of polypharmacy and potentially inappropriate medications (PIMs) in older adults.
Familiarity with geriatric prescribing screening tools, specifically the Beers Criteria and STOPP/START criteria.
Basic knowledge of adverse drug events (ADEs) and drug-drug or drug-disease interactions in the elderly.
Developing patient-centered communication and shared decision-making strategies for tapering or stopping medications.
Managing withdrawal syndromes, rebound effects, and physiological monitoring during the tapering process.
Clinical application of disease-specific deprescribing algorithms (e.g., for proton pump inhibitors, benzodiazepines, or antihypertensives).
Designing and implementing interprofessional deprescribing protocols in outpatient, inpatient, or long-term care settings.
339 views12likes22:40@srilankacollegeofinternalm4691Original Release: 2023-12-21

Deprescribing is a proactive clinical process of medication withdrawal with provisions to restart if needed, supervised by healthcare professionals, aimed at managing polypharmacy and improving outcomes in older adults who are at greater risk of potentially inappropriate prescribing due to multiple comorbidities, different medicine handling, limited psychological reserve, and increased adverse drug reaction risk; the process involves three key steps: obtaining comprehensive patient information about current medications and their impact, identifying drugs that can be deprescribed (those without indication, causing harm, or where benefits no longer outweigh risks), and planning a gradual withdrawal strategy with ongoing communication and monitoring to prevent adverse drug withholding events.